DeWine, 35 other AGs join antitrust suit against Suboxone maker



Ohio is among 36 states suing makers of the heroin addiction treatment drug Suboxone for antitrust violations.

Attorney Gen. Mike DeWine on Thursday announced that Ohio was one of the lead states in the multistate investigation that led to allegations the company that makes prescription Suboxone enaged in a scheme to block generic competitors and cause purchasers to pay artificially high prices.

Reckitt Renckiser Pharmaceuticals, now known as Indivior, is accused of conspiring with MonoSol Rx to switch Suboxone from a tablet version to a film that dissolves in the mouth to prevent or delay generic alternatives from coming onto the market and to maintain monopoly profits. The companies are accused of violating state and federal antitrust laws, according to a statement released by DeWine’s office.

“Some people rely on this prescription drug to treat heroin addiction,” DeWine said. “They shouldn’t be forced to pay higher prices or deprived of options because drugmakers circumvent the law to maximize their profits. People deserve the benefits of fair market competition. When the product involved is used to treat addiction, the implications are even more significant.”

Suboxone is a brand-name prescription drug used to treat opioid addictions by easing addiction cravings.

RELATED: Treatment options debated as overdose deaths mount

The lawsuit was filed Thursday in the U.S. District Court for the Eastern Division of Pennsylvania. It accuses the companies of violating the federal Sherman Act and state laws. Over time, the manufacturer converted the market away from the tablet to the film through marketing, price adjustments and other methods. Ultimately, after the majority of Suboxone prescriptions were written for the film, Reckitt removed the tablet from the U.S. market only. The complaint alleges this was done to keep lower price generic alternatives off the market. Currently, no generic alternative of the film is available. The attorneys general claim that consumers and purchasers have paid artificially high monopoly prices, potentially since October 2009, when generic alternatives of Suboxone might otherwise have become available. During that time, annual sales of Suboxone topped $1 billion, according to the statement.

Download our free mobile apps for breaking news and weather on your smartphone


Next Up in News

Speeding car, not deer, takes out pole on Gettysburg Avenue in Dayton
Speeding car, not deer, takes out pole on Gettysburg Avenue in Dayton
A reported deer strike in the area of North Gettysburg Avenue and Kings Highway in reality was a high-speed crash involving a car that destroyed a...
Charlotte mayor imposes midnight curfew during third night of protests
Charlotte mayor imposes midnight curfew during third night of protests
 CHARLOTTE — After a second night of violent protests over a police-involved shooting, police chief Kerr Putney allowed the victim's...
Poor Will’s Clark County Almanack: Mild freezes ahead
Poor Will’s Clark County Almanack: Mild freezes ahead
The human body is susceptible to the same cosmic influences as the Earth and … body processes ebb and flow with the tides, just as do the crust and...
Hamilton police dog fitted for new body armor
Hamilton police dog, Flash, will soon have his own body armor to protect him while he is on patrol with partner Officer Casey Johnson.
Survivors of traumatic injuries feted at Miami Valley Hospital
Survivors of traumatic injuries feted at Miami Valley Hospital
Six survivors of traumatic injuries were recognized Thursday night at Miami Valley Hospital for their perseverance and grit.
More Stories

You have reached your limit of free articles this month.

Enjoy unlimited access to myDaytonDailyNews.com.

Starting at just 99¢ for 8 weeks.

GREAT REASONS TO SUBSCRIBE TODAY!

  • IN-DEPTH REPORTING
  • INTERACTIVE STORYTELLING
  • NEW TOPICS & COVERAGE
  • ePAPER
X

You have read of free premium articles.

Get unlimited access to all of our breaking news, in-depth coverage and bonus content- exclusively for subscribers. Starting at just 99¢ for 8 weeks.

X

Welcome to myDaytonDailyNews.com

This subscriber-only site gives you exclusive access to breaking news, in-depth coverage, exclusive interactives and bonus content.

You can read free articles of your choice a month that are only available on myDaytonDailyNews.com.